WeedMD To Manufacture Fire & Flower's Revity CBD Product Line

Cannabis manufacturer and distributor WeedMD Inc. WMD WDDMF, which recently agreed to produce a suite of Mary's Medicinals' products, teamed up with Fire & Flower Inc. FAF FFLWF to produce, package and ship its CBD product line.

Under the deal, Fire & Flower’s product offering under the Revity brand name will be available in stores in the province of Saskatchewan by Aug. 14.

The Toronto-based producer and distributor of medical-grade cannabis agreed to manufacture the product line at its extraction hub CX Industries.

In addition, WeedMD said it would utilize its input biomass.

WeedMD's CEO Angelo Tsebelis said they are "proud" Fire & Flower chose to partner with them.

"With our CX extraction business focused on developing high-grade concentrates from trichome-rich biomass, we anticipate a fruitful and long-term relationship with Fire & Flower," added Tsebelis.

Fire & Flower CEO Trevor Fencott highlighted that WeedMD has an "excellent reputation of producing quality products and a track record of innovation."

"Fire & Flower is pleased to launch a wellness-focused brand in the underserved market of regulated CBD products," continued Fencott.

Meanwhile, both companies have been reporting a substantial revenue increase, despite the COVID-19 recession.

Besides the year-over-year revenue growth of 142%, the Canadian cannabis retailer revealed its sales amounted to CA$18.4 million.

Moreover, Fencott explained that both the "Open Fields Distribution Platform" and "Hifyre Digital Retail and Analytics platform" contribute to the Fire & Flower’s overall results as independent revenue opportunities.

According to its first-quarter earnings report, WeedMD saw its revenue increasing by 327% sequentially and 265% over a year.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsRetail Salescannabis industrycannabis sales
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.